Search

Search Results
Results 451 - 460 of 1413 for Active treatment
  • Dothep
    Drug - 7 Sep 2022
    Consumer Medicine Information (CMI) about Dothep intended for persons living in Australia.
  • Dosulepin Viatris (formerly Dosulepin Mylan)
    Drug - 7 Sep 2022
    Consumer Medicine Information (CMI) about Dosulepin Viatris (formerly Dosulepin Mylan) intended for persons living in Australia.
  • DBL Dobutamine
    Drug - 17 Aug 2022
    Consumer Medicine Information (CMI) about DBL Dobutamine intended for persons living in Australia.
  • Reaptan
    Drug - 2 Aug 2022
    Consumer Medicine Information (CMI) about Reaptan (Perindopril/amlodipine [pronounced per-in-do-pril/ am-load-i-peen]) intended for persons living in Australia.
  • Prexum
    Drug - 15 Jul 2022
    Consumer Medicine Information (CMI) about Prexum (perindopril) intended for persons living in Australia.
  • Neo-B12 Injection
    Drug - 13 Jul 2022
    Consumer Medicine Information (CMI) about Neo-B12 Injection intended for persons living in Australia.
  • Samsca
    Drug - 30 Jun 2022
    Consumer Medicine Information (CMI) about Samsca intended for persons living in Australia.
  • Busulfex
    Drug - 28 Jun 2022
    Consumer Medicine Information (CMI) about Busulfex intended for persons living in Australia.
  • DBL Glyceryl Trinitrate
    Drug - 27 Jun 2022
    Consumer Medicine Information (CMI) about DBL Glyceryl Trinitrate intended for persons living in Australia.
  • Trazimera
    Drug - 4 May 2022
    Consumer Medicine Information (CMI) about Trazimera intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback